Issue 004 | U.S. Pilot | US

ERNA

Ernexa Therapeutics Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-11 Filing currency: USD
Internal NCAV Discount 35.9%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
9,996,000USD
Total Liabilities
3,684,000USD
NCAV
6,312,000USD
Cash
9,177,000USD
NCAV per share
5.41USD/share
Evidence
10 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
8
Requires inspection Negative OCF -2,264,000
Latest
-2,264,0002026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001493152-26-022276

Supporting observation Current Ratio > 1.5 2.89
Latest
2.892026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001493152-26-022276

8 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
High NCAV Burn since the previous filing NCAV burn since previous filing >= 10%; previous NCAV must be positive
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Non-Positive Equity ordinary shareholders equity <= 0
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 100.0 on 2016-06-03; reverse 2.0 on 2021-03-25; reverse 20.0 on 2022-10-17; reverse 15.0 on 2025-06-12; reverse 10.0 on 2025-06-30; reverse 25.0 on 2026-03-27

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue 582,000 582,000 68,000 0 n/a 5,800,000 19,806,000 23,335,000 21,274,000 22,312,000
Operating Income -9,319,000 -15,674,000 -21,135,000 -33,217,000 -113,552,000 -6,309,000 -1,762,000 203,000 -1,402,000 -2,278,000
Net Income -14,084,000 -44,539,000 -21,668,000 -24,579,000 -122,306,000 -4,415,000 -2,047,000 -259,000 -1,077,000 -2,923,000
Cash From Operations -7,017,000 -15,836,000 -20,408,000 -20,976,000 -23,488,000 -3,894,000 2,744,000 1,365,000 549,000 23,000
Capex -37,000 -369,000 -19,000 -297,000 -154,000 -39,000 -128,000 -648,000 -728,000 -427,000
Free Cash Flow -7,054,000 -16,205,000 -20,427,000 -21,273,000 -23,642,000 -3,933,000 2,616,000 717,000 -179,000 -404,000
Cash And Equivalents 1,884,000 1,729,000 7,575,000 11,446,000 16,985,000 777,000 3,209,000 2,536,000 3,378,000 5,686,000
Accounts Receivable n/a n/a n/a n/a 684,000 116,000 1,195,000 1,143,000 714,000 928,000
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 3,133,000 2,352,000 9,599,000 13,681,000 18,766,000 1,724,000 6,070,000 6,785,000 9,638,000 10,662,000
Total Assets 5,834,000 5,269,000 49,132,000 22,279,000 32,429,000 3,745,000 14,125,000 14,864,000 16,570,000 16,695,000
Total Current Liabilities 3,113,000 2,938,000 6,573,000 7,654,000 3,677,000 2,360,000 6,095,000 4,024,000 10,747,000 6,643,000
Total Liabilities 3,433,000 3,568,000 46,899,000 10,172,000 25,927,000 2,894,000 9,034,000 7,947,000 11,034,000 12,627,000
Shareholders Equity 2,401,000 1,701,000 2,233,000 12,107,000 6,502,000 851,000 5,091,000 6,917,000 5,536,000 4,068,000
Shares Outstanding 1,166,177 13,932 1,443 1,367 766 20 19 19 17 15
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 252,280 910,000 1,417 814 144,333 1,172,533 191,667 179,200 162,800 126,867
Weighted Avg Shares Basic 252,280 910,000 1,417 814 144,333 1,172,533 191,667 179,200 162,800 126,867
Net Share Count Change (Normalized) 0.1% 849.7% 0.0% Insufficient evidence 146.5% 2.2% 0.9% 14.0% 11.5% Insufficient evidence
Ownership Claim Change (Normalized) -0.1% -89.5% 0.0% Insufficient evidence -59.4% -2.2% -0.9% -12.3% -10.3% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a 487,000 47,000 47,000 1,000 487,000 47,000 47,000 n/a 51,000 n/a 0 n/a 0 n/a n/a n/a n/a n/a
Operating Income -5,590,000 -2,095,000 -1,993,000 -2,501,000 -2,730,000 -2,697,000 -2,259,000 -4,931,000 -5,787,000 -5,765,000 -5,505,000 -4,549,000 -5,316,000 -4,737,000 -8,304,000 -13,880,000 -6,296,000 -9,104,892 -86,332,381 -10,013,130
Net Income -5,506,000 -1,503,000 -1,240,000 -3,139,000 -8,202,000 -5,759,000 -26,604,000 -5,529,000 -6,647,000 -6,153,000 -5,591,000 -4,508,000 -5,416,000 -4,490,000 -7,316,000 -3,398,000 -9,375,000 -8,463,037 -86,055,312 -10,085,317
Cash From Operations -2,264,000 -1,148,000 -1,272,000 -2,532,000 -2,065,000 -3,545,000 -6,285,000 -2,259,000 -3,747,000 -4,661,000 -5,826,000 -3,872,000 -6,049,000 -5,435,000 -6,116,000 -3,993,000 -5,432,000 -6,830,366 -6,422,870 -6,804,837
Capex -2,000 n/a n/a -249,000 -101,000 0 -19,000 -249,000 -101,000 -19,000 0 0 0 -21,000 -43,000 -187,000 -46,000 -147,140 -6,860 0
Free Cash Flow -2,266,000 n/a n/a -2,781,000 -2,166,000 -3,545,000 -6,304,000 -2,508,000 -3,848,000 -4,680,000 -5,826,000 -3,872,000 -6,049,000 -5,456,000 -6,159,000 -4,180,000 -5,478,000 -6,977,506 -6,429,730 -6,804,837
Cash And Equivalents 9,177,000 n/a 3,047,000 4,315,000 1,918,000 1,729,000 4,264,000 2,586,000 5,116,000 7,575,000 4,551,000 1,837,000 5,397,000 11,446,000 13,254,000 19,407,000 23,500,000 16,985,000 24,381,831 50,164,673
Total Current Assets 9,996,000 3,133,000 3,379,000 4,792,000 2,211,000 2,352,000 4,730,000 3,583,000 6,164,000 9,599,000 7,031,000 3,891,000 6,515,000 13,681,000 15,852,000 21,925,000 25,135,000 18,766,000 25,758,317 51,941,173
Total Liabilities 3,684,000 3,433,000 2,602,000 3,140,000 11,009,000 3,568,000 53,111,000 55,012,000 53,069,000 46,899,000 48,686,000 43,088,000 7,728,000 10,172,000 12,113,000 12,123,000 18,065,000 25,927,000 26,354,071 29,526,783
Shares Outstanding 1,166,333 314,160 313,956 306,836 16,630 13,932 13,700 1,443 1,443 1,443 1,443 1,443 1,405 1,367 785 784 766 766 694 690
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 792,000 6,307,000 329,040 207,160 142,000 10,181 361,000 361,000 1,443 1,443 1,443 1,414 1,367 3,051,000 784 784 178,733 3,472,399 674 2,829,867
Weighted Avg Shares Basic 792,000 6,307,000 329,040 207,160 142,000 10,181 361,000 361,000 1,443 1,443 1,443 1,414 1,367 3,051,000 784 784 178,733 3,472,399 674 2,829,867
Net Share Count Change (Normalized) 271.1% 0.1% 4.9% 2048.2% 1.7% 849.7% 0.0% Insufficient evidence 1.8% 0.0% 0.0% 5.5% 0.0% Insufficient evidence 0.0% 109557.6% -99.9% 146.5% 0.2% Insufficient evidence
Ownership Claim Change (Normalized) -73.1% -0.1% -4.7% -95.3% -1.7% -89.5% 0.0% Insufficient evidence -1.8% 0.0% 0.0% -5.2% 0.0% Insufficient evidence -0.0% -99.9% 80655.6% -59.4% -0.2% Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 9,996,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
Total Liabilities 3,684,000USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
Cash 9,177,000USD us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-03-31 1.00 n/a
Shares Outstanding 1,166,333 dei:EntityCommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
Data Vault | sec/companyfacts/cik=0000748592/companyfacts.json
NCAV 6,312,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 5.41USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 35.9% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
n/a
CIK
0000748592
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
26
Imported At
2026-08-02T05:41:05+00:00
Rendered At
2026-08-16T03:29:54+00:00

Run Audit

Mary Run
29510e1968ca4fb386d55ebe1e97a5de
Mary As Of
2026-08-01
Accession
0001493152-26-022276
CIK
0000748592
Mary Filing Date
2026-05-11
Filing Currency
USD
Internal Discount
35.9%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=29510e1968ca4fb386d55ebe1e97a5de; mary_as_of=2026-08-01; mary_filing_date=2026-05-11; mary_accession=0001493152-26-022276; mary_cik=0000748592; gnni_supporting_filing_date=2026-05-11; internal_discount=0.358996; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive